简体
  • 简体中文
  • 繁体中文

热门资讯> 正文

Whitehawk Therapeutics Q3 EPS $(0.26) Misses $0.07 Estimate

2025-11-06 21:37

Whitehawk Therapeutics (NASDAQ: WHWK) reported quarterly losses of $(0.26) per share which missed the analyst consensus estimate of $0.07 by 488.06 percent. This is a 43.48 percent increase over losses of $(0.46) per share from the same period last year.

风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。